XML 43 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2018
Stockholders' Equity Note [Abstract]  
Schedule of Stock by Class
 
Authorized
 
Issued and outstanding
 
Number of shares
 
December 31,
 
December 31,
 
2018
 
2017
 
2018
 
2017
Stock of $0.001 par value:
 
 
 
 
 
 
 
Common stock
200,000,000

 
200,000,000

 
29,576,880

 
28,146,162

Share-based Compensation, Stock Options, Activity
A summary of employees’ stock options activities during the year ended December 31, 2018 is as follows:
 
 
Year ended
 
December 31, 2018
 
Number
 
Weighted
average
exercise
price
 
Aggregate
intrinsic
value
(in thousands)
 
Weighted
average
remaining
contractual
life (years)
Options outstanding at the beginning of the year
1,456,285

 
$
16.172

 
$
47,152

 
4.906

Granted

 
$

 
 
 
 
Exercised
(744,636
)
 
$
14.469

 
 
 
 
Forfeited
(1,981
)
 
$
32.473

 
 
 
 
Options outstanding at the end of the period
709,668

 
$
17.941

 
$
24,810

 
4.513

Options exercisable at the end of the period
687,508

 
$
17.856

 
$
24,093

 
4.439



Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range
The options outstanding as of December 31, 2018 have been separated into ranges of exercise price as follows:
 
Range of
exercise price
 
Options
outstanding
as of
December 31,
2018
 
Weighted
average
remaining
contractual
life (years)
 
Weighted
average
exercise
price
 
Options
exercisable
as of
December 31,
2018
 
Weighted
average
remaining
contractual
life (years)
 
Weighted
average
exercise
price of
options
exercisable
$
1.256

 
 
1.576
 
130,479

 
0.663

 
$
1.282

 
130,479

 
0.663

 
$
1.282

$
6.230

 
 
8.800
 
12,356

 
3.007

 
$
8.039

 
12,356

 
3.007

 
$
8.039

$
12.470

 
 
16.870
 
147,125

 
5.014

 
$
14.030

 
132,541

 
4.781

 
$
13.637

$
19.510

 
 
21.660
 
220,211

 
5.599

 
$
21.174

 
218,573

 
5.594

 
$
21.185

$
22.010

 
 
24.230
 
85,870

 
5.284

 
$
22.364

 
85,870

 
5.284

 
$
22.364

 

 
$29.880
 
 
 
66,349

 
6.145

 
$
29.880

 
60,411

 
6.145

 
$
29.880

 

 
$39.860
 
 
 
47,278

 
5.225

 
$
39.860

 
47,278

 
5.225

 
$
39.860

 

 
 
 
 
 
709,668

 
4.513

 
$
17.941

 
687,508

 
4.439

 
$
17.856

Schedule of Stockholders' Equity Note, Warrants or Rights
The Company’s outstanding options granted to consultants for services as of December 31, 2018 were as follows:
 
Issuance date
Options for
shares of
common stock
 
Exercise price
per share
 
Options
exercisable
 
Exercisable
through
 
(number)
 
 
 
(number)
 
 
February 2013
1,500

 
$
12.470

 
1,500

 
February 2023
August 2013
4,000

 
$
21.140

 
4,000

 
August 2023
March 2014
5,550

 
$
39.860

 
5,550

 
March 2024
May 2014
3,700

 
$
22.010

 
3,700

 
May 2024
November 2014
5,468

 
$
21.660

 
5,468

 
November 2024
May 2015
1,137

 
$
19.510

 
929

 
May 2025
February 2016
2,138

 
$
16.870

 
1,408

 
February 2026
 
23,493

 
 
 
22,555

 
 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following provides a summary of the restricted stock unit activity for the Company for the year ended December 31, 2018:
 
 
Number of
Shares
Underlying
Outstanding
Restricted Stock
Units
 
Weighted-
Average
Grant Date
Fair Value
Outstanding as of January 1, 2018
2,018,121

 
$
27.32

Granted
1,255,824

 
$
53.79

Vested
(671,768
)
 
$
28.54

Forfeited
(162,150
)
 
$
36.89

Unvested as of December 31, 2018
2,440,027

 
$
40.00

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
The Company recognized non-cash stock-based compensation expense in the consolidated statements of operations as follows (in thousands):
 
 
Year ended
 
December 31,
 
2018
 
2017
 
2016
Cost of revenues
$
1,757

 
$
1,078

 
$
699

Research and development
9,645

 
5,209

 
3,052

Sales and marketing
16,081

 
8,542

 
6,104

General and administrative
7,478

 
5,006

 
3,083

Total
$
34,961

 
$
19,835

 
$
12,938